Cancer can recur months, years or even decades after treatment when microscopic cells remain dormant and later begin growing again.
Research into dormant cancer cells is now providing new clues about why some cancers can remain hidden for years before returning.
Research highlighted by the NCI suggests that dormant cancer cells can remain in the body for months, years or even decades.
These cells may remain inactive as minimal residual disease (MRD) or dormant cancer cells.
Researchers are also investigating therapies designed to target dormant cancer cells and the biological mechanisms that allow them to survive.
Cancer can recur months, years or even decades after treatment when microscopic cells remain dormant and later begin growing again. Experts explain why recurrence happens and why long-term surveillance matters.
For someone who has completed cancer treatment and lived cancer-free for years, the possibility of the disease returning can seem almost unimaginable. Yet cancer recurrence can occur months, years and, in some cases, decades after treatment. The reason may lie in microscopic cancer cells that survived initial treatment, remained undetectable and entered a dormant state before eventually becoming active again.
Cancer recurrence does not necessarily mean that the original treatment was unsuccessful. The National Cancer Institute suggest that recurrent cancer can develop when a small number of cancer cells survive treatment but are too few to be detected by follow-up tests. Over time, these cells can grow enough to become detectable.
Advertisement
The biology of recurrence is complex and varies according to the cancer type, stage, tumour characteristics, treatment received and individual factors. Research into dormant cancer cells is now providing new clues about why some cancers can remain hidden for years before returning.
How can cancer come back after years?
Dr Kunal Sharma, Vice President & Head - Integrated Onco-Pathology and Lead – Digital Pathology & AI Initiatives, Agilus Diagnostics, said one of the most difficult questions for patients is why cancer can return after they have been apparently healthy for many years.
More from Health More from Health
According to Sharma, some cancers can leave behind a very small number of cells that remain dormant or inactive for a prolonged period. These cells may not produce symptoms and can remain below the detection limits of routine investigations.
“Why has my cancer come back after so many years?” is therefore not necessarily evidence that the initial treatment failed. Cancer behaviour can vary considerably depending on its type, stage, genetic characteristics and the overall health of the patient.
Research highlighted by the NCI suggests that dormant cancer cells can remain in the body for months, years or even decades. Scientists are still investigating what causes these cells to leave their dormant state and begin forming new tumours.
Advertisement
What makes dormant cancer cells become active?
Dr Mohit Agarwal, Principal Director & Head Medical Oncology, Fortis Hospital (Shalimar Bagh) said some cancer cells can survive treatment in a “hibernating” or dormant state.
These cells can be too small to appear on scans or routine tests and may remain undetected for years. Changes in the body's environment, hormonal shifts or changes in immune function may contribute to their eventual reactivation.
Once these cells begin multiplying again, a recurrence can develop. Depending on the cancer, it may return at the original site, nearby lymph nodes or in another part of the body.
Dr Agarwal stressed that recurrence should not automatically be interpreted as evidence that the first treatment failed.
“It simply shows how clever and adaptable cancer can be,” he said, adding that researchers are studying ways to identify and eliminate dormant cells before they can lead to clinically detectable disease.
Recurrence does not mean the first treatment failed
For patients, the distinction is important. Recurrence means that cancer has returned after a period when it could not be detected, whereas a second primary cancer is a new, biologically different cancer.
Advertisement
Dr Ashok Kumar Vaid, Chairman, Medical Oncology & Cancer Care, Medanta (Gurugram), said completing treatment and remaining cancer-free for several years is a significant milestone, but it does not eliminate the possibility of recurrence in every cancer.
He explained that a small number of cancer cells may survive surgery, chemotherapy, radiation, targeted therapy or other treatments. These cells may remain inactive as minimal residual disease (MRD) or dormant cancer cells.
Changes in the immune response, hormonal environment, inflammation or genetic alterations within tumour cells may subsequently contribute to their reactivation.
The likelihood of recurrence is not the same for every patient. It depends on factors including the original cancer type and stage, tumour biology and the treatment received. The American Cancer Society also notes that recurrence risk varies substantially between cancers and individual circumstances.
Why long-term follow-up remains important
The possibility of late recurrence is one reason cancer care does not necessarily end when the final chemotherapy session, surgery or radiation treatment is completed.
Dr Sharma said regular follow-up, appropriate imaging and laboratory monitoring can help doctors identify changes early. Patients should also report persistent or unusual symptoms rather than assuming they are unrelated to their previous cancer.
These can include unexplained weight loss, unusual fatigue, new lumps or persistent pain. However, such symptoms do not automatically indicate recurrence; many can have other causes and should be assessed by a doctor.
The American Cancer Society recommends that cancer survivors follow the surveillance plan developed by their healthcare team, with the nature and frequency of examinations depending on the cancer they had and their individual risk.
Can new tests detect cancer before it appears on scans?
One of the most promising areas of research is the search for minimal residual disease before it becomes visible on conventional imaging.
Vaid pointed to advances including liquid biopsy, circulating tumour DNA (ctDNA) analysis and MRD testing, which are being studied and, in selected cancers, used to detect microscopic disease.
These approaches analyse biological material released by tumours into the bloodstream and may potentially identify residual disease earlier than conventional methods in appropriate clinical settings.
However, these technologies should not be presented as universal tests that can currently predict or prevent every cancer recurrence. Their usefulness varies by cancer type, clinical setting and the specific test being used.
Researchers are also investigating therapies designed to target dormant cancer cells and the biological mechanisms that allow them to survive. The NCI says understanding how dormant cells are maintained and reactivated could eventually help develop strategies to prevent metastatic recurrence.
Cancer-free for years? Why survivors should still stay alert
For many survivors, years without detectable disease are an important sign of successful treatment. In general, recurrence is more common during the first few years after treatment, but some cancers can return much later.
That does not mean cancer survivors should live in constant fear. Rather, experts emphasise the importance of appropriate long-term follow-up, awareness of new or persistent symptoms and continued communication with the treating team.
As Sharma puts it, recovery is more than simply completing treatment. Long-term cancer care also involves monitoring health over time and ensuring that any concerning change is evaluated promptly.
For patients who have remained cancer-free for years, the message is therefore one of vigilance rather than alarm: a late recurrence is possible, but it does not mean the original treatment was futile and advances in cancer biology are steadily improving doctors' understanding of why cancer returns and how it may one day be stopped before it does.
